Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

• Conditions: Guillain-Barre Syndrome; Multifocal Motor Neuropathy; CIDP

• Registration Number: NCT01655394
• Lead Sponsor: University of Cologne

Brief Summary

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored.

Detailed Description

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored

Study Timeline

• Study First Submitted: 2012-07-30
• Study First Submitted QC: 2012-07-31
• Study First Posted: 2012-08-01
• Study Start: 2012-10
• Status Verified: 2014-12
• Primary Completion: 2014-12
• Last Update Submitted: 2014-12-11
• Last Update Posted: 2014-12-12
• Study Completion: 2016-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• immune neuropathy
• age above 18 y
• IVIg treatment

exclusion:

• no IVIg treatment

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical Improvement	6 Months

Trial Locations

Locations (1)

University of Cologne; 🇩🇪 Cologne, Germany